Larry is currently Chairman and CEO of Talecris Biotherapeutics, a leading global biotech producing plasma derived protein therapeutics for patients with chronic and acute disease states such as primary immune deficiency, hemophilia and genetic emphysema. Larry worked with two private equity groups in connection with the acquisition that formed Talecris Biotherapeutics in 2005. In 2008, global revenues exceeded $1.3 billion. Larry also serves on the board of Centric Health Resources, an entity focused on improving health outcomes by coupling disease state management with therapeutic treatments.

Under his leadership, Talecris has grown from approximately 1600 to 4700 employees in just four years. Larry is particularly enthusiastic regarding new plasma-derived and recombinant proteins in the R&D pipeline.

After receiving his BS in Chemical Engineering from Cornell in ’79 and his MS from MIT in ’81, Larry started his career in process research for ARCO Chemical. He spent 15 years in research, development and manufacturing before moving on to business management. He now advocates to all new grads to take their time building the foundation for their career before hopping to the next opportunity.

Larry formerly served on the board of Life’s Work, a non-profit organization focused on helping people with physical and mental disabilities. He is now an active supporter of patient organizations focused on rare chronic diseases including the Immune Deficiency Foundation, the Jeffrey Modell Foundation and the Alpha-1 Foundation.

At the time of our 35th reunion, Larry had finished a successful run as Chairman and CEO of Talecris, having completed an IPO on the NASDAQ in 2009 followed by a sale to a competitor in 2011. Larry is now focused on giving back to the community, primarily by providing grants that demonstrate best practices in a wide range of health care such as pre-conception genetic screening, evolving personalized medicine, reducing hospital re-admissions, improving long-term care transitions and palliative care.

At the time of our 40th reunion, Larry is continuing to give back to the community by providing grants that demonstrate best practices in a wide range of health care such as genetic screening, personalized medicine and palliative care. He also maintains his interest in early stage bio, device, and diagnostic start-ups.